Epilepsy & Seizures
FDA/CDC
Cannabis: Doctors tell FDA to get out of the weeds
Unregulated use of cannabidiol was the chief concern of many physicians.
Latest News
FDA approves midazolam nasal spray for seizure clusters
The Food and Drug Administration has approved midazolam (Nayzilam) nasal spray for the acute treatment of intermittent, stereotypic episodes of...
Conference Coverage
Insomnia symptoms correlate with seizure frequency
PHILADELPHIA – Nearly a quarter of adults with epilepsy have moderate or severe insomnia, and insomnia symptoms are associated with depression,...
Conference Coverage
More than one in six patients with status epilepticus are readmitted after hospital discharge
PHILADELPHIA – Identifying patients at high risk of readmission could reduce their financial and clinical burdens....
Conference Coverage
Changes in brain networks may predict MS worsening
PHILADELPHIA – Structural and functional network MRI measures appear to identify patients at high risk for increased...
Conference Coverage
Patients describe significant impact of epilepsy on their lives
PHILADELPHIA – Symptoms reported most commonly were twitching/tremors, confusion, difficulty talking, impaired/loss of consciousness, stiffening,...
Conference Coverage
Cannabidiol reduces seizures in Dravet syndrome
PHILADELPHIA – Two dosages of the CBD treatment appear to have similar efficacy, but the lower dose may be more...
Conference Coverage
Angelman syndrome treatment safe, well-tolerated, and effective in exploratory analyses
PHILADELPHIA – Experimental treatment may benefit adolescents and adults with Angelman syndrome.
Latest News
Postvaccination febrile seizures are no more severe than other febrile seizures
Vaccine-proximate febrile seizures accounted only for a small proportion of febrile seizures in the study.
News from the FDA/CDC
FDA concerned about e-cigs/seizures in youth
Between 2010 and early 2019, the FDA and poison control centers received 35 reports of seizures that mentioned the use of e-cigarettes
From the Journals
Valproate, topiramate prescribed in young women despite known teratogenicity risks
These findings suggest a lack of awareness of the teratogenic risks of valproate and topiramate on the part of physicians and patients.